Monday, August 15, 2022
Home Antibody success in targeting amyloid plaque Antibody success in targeting amyloid plaque

Antibody success in targeting amyloid plaque

Antibody, amyloid, Research, Washington Medical School, Alzheimer’s, bleeds, strokes, dementia, Washington University School of Medicine in St Louis, Apoliprotein E, APOE, David Holtzman, HAE-4

Researchers from Washington Medical School haveused an antibody to target just a small component of amyloid plaque in Alzheimer’s, and avoided the failings of other antibody drugs which often resulted in bleeds and strokes.